1-20 of 54
Keywords: Breast cancer
Close
Sort by
Journal Articles
Journal Articles
Oncol Res Treat (2023) 46 (7-8): 303–311.
Published Online: 09 June 2023
... pyrotinib to trastuzumab, docetaxel, and carboplatin versus placebo, trastuzumab, docetaxel, and carboplatin in Chinese patients with human epidermal receptor 2 (HER2)-positive early or locally advanced breast cancer ( ClinicalTrials.gov identifier: NCT03756064). Methods: Sixty-nine women with HER2-positive...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (11): 681–692.
Published Online: 19 August 2022
... molecular subtypes of breast cancer and assessed the feasibility of its adoption in varying phases of treatment. Due to the promising preclinical and clinical investigations, it is expected that MCT in combination with other treatments will enhance the advantages of this strategy and apply it to clinical...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Oncol Res Treat (2022) 45 (1-2): 26–36.
Published Online: 16 December 2021
..., there are 9 approved ADCs overall and 3 for breast cancer. So, the pace of development seems to pick up with over 100 candidates in various stages of clinical development. Many ADCs of the newest generation are optimized to elicit a so-called bystander effect, to increase efficacy and tackle heterogeneous...
Journal Articles
Journal Articles
Oncol Res Treat (2022) 45 (1-2): 18–25.
Published Online: 24 November 2021
...Kim M. Pabst; Thomas Decker; David Kersting; Timo Bartel; Miriam Sraieb; Ken Herrmann; Robert Seifert Background: A variety of therapeutic approaches are employed to treat patients suffering from breast cancer. Likewise, a broad spectrum of imaging ligands has been introduced for noninvasive...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Oncol Res Treat (2021) 44 (7-8): 400–407.
Published Online: 08 June 2021
...-positive HER2-negative breast cancer. However, the predictive factors for the treatment response to CDK4/6 inhibitor therapy are poorly elucidated. Early changes in the by [ 18 F]-fluorodeoxyglucose positron emission tomography (FDG-PET) uptake of tumors receiving different kinds of therapy have proven...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Oncol Res Treat (2021) 44 (1-2): 36–42.
Published Online: 26 November 2020
... the clinical significance of LRG1 in breast cancer. Objectives: The purpose of this work was to validate the correlation between LRG1 expression and prognosis in early breast cancer. Methods: We utilized an LRG1 detection agent in 330 cases of early breast cancer. The correlation of LRG1 expression...
Journal Articles